These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10692180)
1. Sebaceous carcinoma of the breast. Varga Z; Kolb SA; Flury R; Burkhard R; Caduff R Pathol Int; 2000 Jan; 50(1):63-6. PubMed ID: 10692180 [TBL] [Abstract][Full Text] [Related]
2. Sebaceous carcinoma of the breast: case report and review of the literature. Hisaoka M; Takamatsu Y; Hirano Y; Maeda H; Hamada T Virchows Arch; 2006 Oct; 449(4):484-8. PubMed ID: 16944238 [TBL] [Abstract][Full Text] [Related]
3. Sebaceous Carcinoma in Situ Masquerading Clinically and Histologically as Paget Disease of the Breast. Tjarks BJ; Kerkvliet AM; Jassim AD S D Med; 2018 Aug; 71(8):350-353. PubMed ID: 30110525 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion. Kusama R; Fujimori M; Matsuyama I; Fu L; Ishii K; Hama Y; Asanuma K; Shingu K; Kobayashi S; Tsuchiya S Pathol Int; 2000 Oct; 50(10):793-800. PubMed ID: 11107051 [TBL] [Abstract][Full Text] [Related]
5. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Leong AS; Sormunen RT; Vinyuvat S; Hamdani RW; Suthipintawong C Am J Clin Pathol; 2001 May; 115(5):709-18. PubMed ID: 11345835 [TBL] [Abstract][Full Text] [Related]
6. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Soslow RA; Carlson DL; Horenstein MG; Osborne MP Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102 [TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers. Moreno A; Lloveras B; Figueras A; Escobedo A; Ramon JM; Sierra A; Fabra A Mod Pathol; 1997 Nov; 10(11):1088-92. PubMed ID: 9388058 [TBL] [Abstract][Full Text] [Related]
8. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Frolik D; Caduff R; Varga Z Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion]. Fu L; Fu XY; Kusama R; Matsuyama I; Liu TH; Tsuchiya S Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):221-4. PubMed ID: 15256112 [TBL] [Abstract][Full Text] [Related]
10. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling. Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530 [TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Wallace ML; Smoller BR Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and immunohistochemical features of a sebaceous carcinoma arising within a benign dermoid cyst of the ovary. Ribeiro-Silva A; Chang D; Bisson FW; Ré LO Virchows Arch; 2003 Oct; 443(4):574-8. PubMed ID: 12836022 [TBL] [Abstract][Full Text] [Related]
13. [Primary sebaceous carcinoma of the breast; three casuistic reports]. Kinkor Z; Meciarová I; Havlícek F Ceska Gynekol; 2010 Feb; 75(1):50-3. PubMed ID: 20437837 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Gatalica Z Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507 [TBL] [Abstract][Full Text] [Related]
15. Signet-ring cell carcinoma of the breast. Liu SM; Chen DR Pathol Int; 2000 Jan; 50(1):67-70. PubMed ID: 10692181 [TBL] [Abstract][Full Text] [Related]
16. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients. Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730 [TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature. Klingen TA; Chen Y; Gundersen MD; Aas H; Westre B; Sauer T Diagn Pathol; 2010 Jun; 5():37. PubMed ID: 20565809 [TBL] [Abstract][Full Text] [Related]
18. Utility of Sox10 labeling in metastatic breast carcinomas. Nelson ER; Sharma R; Argani P; Cimino-Mathews A Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711 [TBL] [Abstract][Full Text] [Related]
19. Carcinoid-like pattern in sebaceous neoplasms: another distinctive, previously unrecognized pattern in extraocular sebaceous carcinoma and sebaceoma. Kazakov DV; Kutzner H; Rütten A; Mukensnabl P; Michal M Am J Dermatopathol; 2005 Jun; 27(3):195-203. PubMed ID: 15900121 [TBL] [Abstract][Full Text] [Related]
20. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]